Maps and Statistics about Hepatitis B and C in Canada

Who has hepatitis B and hepatitis C in Canada? In order to eliminate viral hepatitis, it is very important to know the answers to this complex question! Looking at Canada's hepatitis C statistics, the largest group of people with hepatitis C is made up of people born outside Canada, followed by former users of IV drugs, then by current users of IV drugs (PWID). Hepatitis B and C are spread through blood-to-blood contact, so IV drug use is a logical ri

Newcomer & Immigrant Outreach

Click HERE for TRANSLATIONS of hepatitis B or hepatitis C information in አማርኛ عربى বাংলা  简体中文  中國傳統的  English français  فارسی  pilipino  Deutsch  हिंदी Italiano 한국어 ພາສາລາວ  Монгол Oromo ਪੰਜਾਬੀ  Soomaali  Español  Kiswahili  தமிழ்   ภาษาไทย  ትግርኛ   Türk  اردو   Tiếng Việt Why is HepCBC especially trying to connect with newcomers and immigrants from certain countries, and the organizations to which they belong or visit? It is because the countrie

Rural, Remote, Northern

RURAL, REMOTE, & NORTHERN COMMUNITIES How can we eliminate viral hepatitis in small, isolated communities such as in rural parts of BC's Interior, Kootenays, or the North? There is a lack of doctors, there are few if any specialists, and frankly it's really hard to get confidential hepatitis testing or treatment when the Community Health Representative at your tiny health unit is your sister-in-law, right? We're happy to say help is on the way:

HepCBC Prison Visitation Schedule and Info Page

HepCBC Prison Visitations (Community Resource Expos) to Federal Prisons in British Columbia, organization MANY THANKS to John Howard Society Schedule of Upcoming Visits to Federal Institutions: VISIT #4, November, 2019 Monday, Nov. 4, 2019: Matsqui Institution, Abbotsford, 8:30 am - 11:00 am Monday, Nov. 4, 2019: Pacific Institution, Abbotsford, 1:00 pm - 3:30 pm Tuesday, Nov. 5, 2019 Kwikwexwelhp Healing Village, Harrison Lake, 9:30 am - 11:00 am

First Nations, Métis, and Inuit

Eliminating Viral Hepatitis in Aboriginal Communities of BC British Columbia's Aboriginal communities (both rural and urban) are at particular risk of viral hepatitis (B and C) for a variety of reasons, including a common practice of shared vaccination needles a few decades back, frequent "top-up" transfusions following childbirth, various Residential school practices, endemic hepatitis B in the far north, distrust of confidentiality in small local health

Pamphlets & Posters

Our pamphlets and posters about hepatitis B and C are aimed at various communities: General population and baby boomers Newcomer/immigrant communities (translations available) Aboriginal/northern/remote communities Prison and former prisoner communities IVDU and MSM communities All of the publications on this page can be downloaded (PDFs).  Click on the Thumbnails below to access the printable, high-resolution versions. All posters are

Devising a Strategy to Control the HCV Epidemic in British Columbia, Canada

CROIConference Dates and Location: February 22–25, 2016 | Boston, MassachusettsAbstract Number: 533Devising a Strategy to Control the HCV Epidemic in British Columbia, CanadaAuthor(s): Ignacio Rozada1; Julio Montaner2; Mark W. Hull2; Viviane D. Lima2 1British Columbia Cntr for Excellence in HIV/AIDS, Vancouver, BC, Canada;2BC Cntr for Excellence in HIV/AIDS, Vancouver, BC, CanadaAbstract Body: In 2012, less than 1% of the estimated 12,000 hepatitis C (HCV)

Decision about New Hepatic Encephalopathy Drug Urged by HepCBC

On Monday, September 28, 2015, HepCBC sent a letter (text below) out to all the Provincial Health Ministers except Quebec's, telling them why it is important to patients that they make a decision soon about whether to cover a new hepatic encephalopathy drug, rifaximin. For reference you can read: HepCBC's Patient Group report to the federal government (CADTH) HERE (includes Jan. 12, 2015 revision added on request of CADTH) HepCBC's Patient Group re

View all hepatitis C drug Patient Group input from HepCBC

We are asking for patients to give us input about a new treatment for genotype 4 patients. Are you curious how we use this data?  Want to see what HepCBC tells BC Pharmacare, or the federal drug review agencies about patients' opinions of new hepatitis C treatments? Exactly what did HepCBC tell them about Daklinza (daclatasvir), Holkira Pak (ombitasvir, paritaprevir, ritonavir, and dasabuvir), Harvoni (sofosbuvir+ledipasvir), Sovaldi (sofusbovir), Sunpr...